USD 13.65 billion
Atopic Dermatitis Drugs Market Size, Share, Growth Analysis, By Drug Class(Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics), By Route Of Administration(Topical, Injectable, Oral), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35I2166 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|Tables:
62
|Figures:
75
Atopic Dermatitis Drugs Market Insights
Global Atopic Dermatitis Drugs Market size was valued at USD 13.65 billion in 2022 and is poised to grow from USD 14.91 billion in 2023 to USD 30.14 billion by 2031, growing at a CAGR of 9.2% during the forecast period (2024-2031).
The Global Atopic Dermatitis Drugs Market is a dynamic and rapidly expanding sector in the pharmaceutical industry, dedicated to the development, production, and distribution of medications for the management of atopic dermatitis, a chronic inflammatory skin condition commonly known as eczema. The market has witnessed significant growth owing to the increasing prevalence of atopic dermatitis globally and the growing demand for effective and safe treatment options. Key pharmaceutical companies are engaged in fierce competition, striving to introduce novel drugs and therapies to cater to the unmet needs of patients suffering from atopic dermatitis. The market is also benefiting from advancements in technology, such as the development of targeted drug delivery systems, wearable devices for monitoring and managing symptoms, and telemedicine platforms, enabling remote consultations and personalized care for individuals with atopic dermatitis. The market offers a diverse range of treatment modalities, including topical corticosteroids, calcineurin inhibitors, immunomodulators, and biologic agents, each with their own unique mechanism of action and benefits. The market is also benefiting from advancements in technology, such as the development of targeted drug delivery systems, wearable devices for monitoring and managing symptoms, and telemedicine platforms, enabling remote consultations and personalized care for individuals with atopic dermatitis. There is a growing focus on personalized medicine and precision treatments, with an emphasis on targeted therapies to enhance treatment outcomes and patient satisfaction. Additionally, technological advancements, research and development initiatives, and strategic collaborations are driving innovation in this market, promising a bright future with more effective and tailored solutions for individuals living with atopic dermatitis.
US Atopic Dermatitis Drugs Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Topical
Fastest Growth
Topical
Growth Rate
9.2% CAGR
Global Atopic Dermatitis Drugs Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Atopic Dermatitis Drugs Market Segmental Analysis
Global Atopic Dermatitis Drugs Market is segmented By Drug Class, By Route Of Administration, By Distribution channel and Region. Based on Drug Class, the market can be segmented into Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others. Based on Route of Administration, the market can be segmented into Topical, Injectable, Oral. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis by Route of administration
The dominant segment in the Global Atopic Dermatitis Drugs Market based on the route of administration is the topical segment. Topical medications, such as creams, ointments, and lotions, are widely prescribed as first-line treatments for mild to moderate atopic dermatitis. They are convenient to use, easily accessible, and offer localized relief by directly targeting the affected skin areas. Topical drugs also provide a favorable safety profile and are generally well-tolerated by patients, contributing to their widespread adoption and dominance in the market.
On the other hand, the fastest-growing segment in the Global Atopic Dermatitis Drugs Market is the injection segment. With the emergence of biologic agents and immunomodulators, injectable therapies have gained significant traction in the treatment of moderate to severe atopic dermatitis. These drugs are administered via subcutaneous or intravenous routes, offering targeted systemic action to modulate the immune response associated with the condition. The rapid growth of the injection segment can be attributed to the increasing demand for more potent and effective treatments, especially among patients who have not responded adequately to topical or oral therapies. Additionally, the availability of biologic agents with improved efficacy and a longer duration of action has fueled the adoption of injectable treatments in atopic dermatitis management.
Analysis by Drug Class
The dominant segment in the Global Atopic Dermatitis Drugs Market based on drug class is the corticosteroids segment. Corticosteroids have been widely used for decades in the treatment of atopic dermatitis due to their potent anti-inflammatory properties. They help reduce itching, redness, and swelling associated with the condition. Corticosteroids are available in various forms, including topical creams, ointments, and oral formulations, making them easily accessible for patients across different severity levels of atopic dermatitis. The well-established efficacy, affordability, and familiarity of corticosteroids contribute to their dominance in the market
The fastest-growing segment in the Global Atopic Dermatitis Drugs Market is the biologics segment. Biologic agents, such as monoclonal antibodies, specifically target molecules and pathways involved in the immune response associated with atopic dermatitis. They offer a novel and targeted approach for the treatment of moderate to severe atopic dermatitis, particularly in patients who have not responded well to other therapies. The rapid growth of the biologics segment can be attributed to the increasing understanding of the underlying mechanisms of atopic dermatitis and the development of innovative biologic drugs with improved efficacy and safety profiles. Biologics are revolutionizing the management of atopic dermatitis and are expected to play a significant role in shaping the future of treatment options for this condition.
Global Atopic Dermatitis Drugs Market By Route of administration
To get detailed analysis on other segments, Request For Free Sample Report
Atopic Dermatitis Drugs Market Regional Insights
North America dominated the Global Atopic Dermatitis Drugs Market. This can be attributed to several factors, including the high prevalence of atopic dermatitis in the region, advanced healthcare infrastructure, robust research and development activities, and favorable reimbursement policies. North America is home to major pharmaceutical companies and research institutions focused on developing innovative therapies for atopic dermatitis, driving market dominance in the region.
The fastest-growing region in the Global Atopic Dermatitis Drugs Market is Asia Pacific. This growth can be attributed to several factors, including the rising prevalence of atopic dermatitis, improving healthcare infrastructure, increasing awareness among patients and healthcare providers, and expanding access to healthcare services. Moreover, rapid urbanization, changing lifestyles, and a shift towards westernized diets are contributing to the increasing burden of atopic dermatitis in the Asia Pacific region. As a result, there is a growing demand for effective treatment options, leading to the fastest market growth in this region.
Global Atopic Dermatitis Drugs Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Atopic Dermatitis Drugs Market Dynamics
Drivers
Increasing prevalence of atopic dermatitis
- One key driver for the Global Atopic Dermatitis Drugs Market is the increasing prevalence of atopic dermatitis worldwide. Atopic dermatitis is a common and chronic inflammatory skin condition that affects a significant number of individuals globally, including both children and adults. The rising incidence of atopic dermatitis can be attributed to various factors such as genetic predisposition, environmental triggers, and lifestyle changes. The growing prevalence of atopic dermatitis is driving the demand for effective treatment options to alleviate the symptoms and improve the quality of life for affected individuals. This increased demand has created a favorable market environment for pharmaceutical companies to develop and introduce new drugs and therapies.
Restraints
High cost of atopic dermatitis drugs
- A notable restraint for the Global Atopic Dermatitis Drugs Market is the high cost of atopic dermatitis drugs. Many of the advanced therapies, such as biologics, can be expensive, making them less accessible to certain patient populations. The cost burden associated with these medications can limit their adoption and impact the overall market growth to some extent.
Request Free Customization of this report to help us to meet your business objectives.
Atopic Dermatitis Drugs Market Competitive Landscape
The competitive landscape of the Global Atopic Dermatitis Drugs Market is characterized by intense competition among key players in the pharmaceutical industry. These companies are engaged in extensive research and development activities to develop innovative drugs and therapies for the effective management of atopic dermatitis. There is a focus on developing targeted and personalized treatment options to cater to the specific needs of patients. Additionally, strategic collaborations, partnerships, and licensing agreements are prevalent in the market as companies seek to expand their product portfolios and enhance their market presence. Market players are also investing in marketing and promotional activities to increase awareness about their products and gain a competitive edge.
Top Player’s Company Profiles
- Pfizer Inc. (US)
- Sanofi (France)
- AbbVie Inc. (US)
- GALDERMA LABORATORIES, L.P. (Switzerland)
- Eli Lilly and Company (US)
- Regeneron Pharmaceuticals Inc. (US)
- LEO Pharma Inc. (Denmark)
- Otsuka Pharmaceutical Co., Ltd. (Japan)
- Novartis AG (Switzerland)
- Incyte Corporation (US)
- Astellas Pharma Inc. (Japan)
- Bristol Myers Squibb (US)
- Johnson & Johnson (US)
- Takeda Pharmaceutical Company Limited (Japan)
- GlaxoSmithKline plc (UK)
- Boehringer Ingelheim International GmbH (Germany)
- Celgene Corporation (US)
- Meda AB (Sweden)
- Pierre Fabre Group (France)
- Bayer AG (Germany)
Recent Developments
- In October 2022, Leo Pharma initiated a cross-cultural awareness campaign focusing on atopic dermatitis. This campaign showcased the experiences of four individuals living with chronic skin disease, hailing from France, Italy, Germany, and Spain.
- In June 2022, Sanofi obtained approval from the US Food and Drug Administration (FDA) for Dupixent (dupilumab) to treat children aged 6 months to 5 years with moderate-to-severe atopic dermatitis. This approval was granted for cases where the disease is not effectively managed with topical prescription therapies or when such therapies are not recommended.
- In April 2021, AbbVie announced the submission of a supplemental New Drug Application (sNDA) for the review of RINVOQ as a treatment for adolescent and adult patients with atopic dermatitis. This extension aims to evaluate the efficacy and safety of RINVOQ in this particular patient population.
Atopic Dermatitis Drugs Key Market Trends
- One key market trend in the Global Atopic Dermatitis Drugs Market is the increasing focus on biologic therapies. Biologic agents, such as monoclonal antibodies, have gained significant attention and acceptance in the treatment of moderate to severe atopic dermatitis. These therapies target specific molecules and pathways involved in the immune response associated with the condition, providing a targeted approach to managing the disease. The trend towards biologic therapies is driven by their high efficacy and potential for long-lasting remission, offering a promising treatment option for patients who have not responded well to traditional therapies. This trend reflects a shift towards precision medicine and personalized treatment approaches in the field of atopic dermatitis.
Atopic Dermatitis Drugs Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our Global Atopic Dermatitis Drugs Market analysis, the market is a rapidly growing sector within the pharmaceutical industry, driven by the increasing prevalence of atopic dermatitis worldwide. The market offers a wide range of treatment options, including topical corticosteroids, biologic agents, PDE4 inhibitors, and others. Corticosteroids dominate the market, while biologics represent the fastest-growing segment. The market is characterized by intense competition among key players, with a focus on research and development activities to develop innovative therapies. There is also a growing emphasis on personalized and targeted treatments. North America dominated the market, while the Asia Pacific region is experiencing the fastest growth. Key drivers include the increasing prevalence of atopic dermatitis and the need for effective treatment options, while the high cost of drugs acts as a restraint. The market is witnessing trends towards biologic therapies and precision medicine.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 13.65 billion |
| Market size value in 2031 | USD 30.14 billion |
| Growth Rate | 9.2% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Atopic Dermatitis Drugs Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Atopic Dermatitis Drugs Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Atopic Dermatitis Drugs Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Atopic Dermatitis Drugs Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Atopic Dermatitis Drugs Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Atopic Dermatitis Drugs Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
